Death following ingestion of MDMA (ecstasy) and moclobemide.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12603236.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Four deaths following the ingestion of moclobemide and MDMA ('ecstasy') are described. The probable cause of death in each case was serotonin syndrome as a result of an interaction between the two drugs. As none of the victims had been prescribed moclobemide it seems that each had taken the drug to enhance the effects of MDMA, with fatal consequences. Warnings are needed against misinformed attempts to potentiate the pharmacological effects of illicit drugs.
Medical subject headings
- Hallucinogens
- Moclobemide
- Monoamine Oxidase Inhibitors
- N-Methyl-3,4-methylenedioxyamphetamine
- Serotonin Agents
- Serotonin Syndrome